As president of Mylan, Rajiv leads all global commercial and operational activities for the company. He actively promotes the importance and necessity of quality within the company and industry, enhancing a long-standing commitment to high-quality standards. Prior to joining Mylan in 2007, Rajiv was the CEO of Matrix Laboratories, which was later acquired by Mylan and was instrumental in the company’s positioning as a leading global pharmaceutical company. He also held positions at Sandoz and Ranbaxy Laboratories prior to 2005. Rajiv received his bachelor’s and master’s degrees from Punjab University in India.

In response to COVID-19, Mylan has been supporting communities around the world including India, where the Mylan India Corporate Social Responsibility Fund is contributing to the PM-CARES fund. Mylan actively engages in community efforts and initiatives around the world. Following Hurricane Maria in 2018, the Mylan Charitable Foundation approved a $1 million grant to assist in Puerto Rico’s recovery.